Herantis Pharma: Our H2 Comment – Redeye Publicerad 4 mar 2022 kl 8.03 Redeye comments on the H2 report from Herantis Pharma and reiterate our view of the company.https://www.redeye.se/research/835579/herantis-pharma-our-h2-comment?utm_source=finwire&utm_medium=RSSRedeye